| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |